NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹2,194 Cr | ₹1,751 Cr | ₹912 Cr | ₹264 Cr | ₹604 Cr |
What is the latest Operating Profit of NATCO PHARMA ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹2,194 Cr |
| Mar2025 | ₹1,751 Cr |
| Mar2024 | ₹912 Cr |
| Mar2023 | ₹264 Cr |
| Mar2022 | ₹604 Cr |
How is Operating Profit of NATCO PHARMA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,194 Cr | 25.26 | |
| Mar2025 | ₹1,751 Cr | 92.10 | |
| Mar2024 | ₹912 Cr | 246.00 | |
| Mar2023 | ₹264 Cr | -56.36 | |
| Mar2022 | ₹604 Cr | - | |
Compare Operating Profit of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,936.3 Cr | 0.8% | 3.7% | 2.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,291.0 Cr | -1.8% | 7.6% | 11.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹305,014.0 Cr | 3.7% | 27.2% | 71.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,333.0 Cr | -2.3% | 1.5% | 23.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,017.0 Cr | 0.6% | 13.4% | 15.7% | Stock Analytics | |
| CIPLA | ₹112,539.0 Cr | -1.3% | 6.1% | -6.9% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 0.8% |
3.7% |
2.1% |
| SENSEX | 0.7% |
11.7% |
-2% |
You may also like the below Video Courses